Deutsche Bank AG Takes $129,000 Position in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Deutsche Bank AG purchased a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 6,376 shares of the company’s stock, valued at approximately $129,000.

A number of other institutional investors and hedge funds have also bought and sold shares of GRDN. R Squared Ltd bought a new position in Guardian Pharmacy Services during the fourth quarter worth $30,000. BNP Paribas Financial Markets bought a new position in Guardian Pharmacy Services during the fourth quarter worth $37,000. Compass Financial Services Inc bought a new position in Guardian Pharmacy Services during the fourth quarter worth $58,000. JPMorgan Chase & Co. bought a new position in Guardian Pharmacy Services during the fourth quarter worth $77,000. Finally, Quantbot Technologies LP bought a new position in Guardian Pharmacy Services during the fourth quarter worth $81,000.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Wall Street Zen downgraded shares of Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research note on Saturday, May 24th. Raymond James set a $28.00 price target on shares of Guardian Pharmacy Services and gave the stock an “outperform” rating in a research note on Wednesday, May 14th. Finally, Truist Financial reiterated a “buy” rating and set a $28.00 price target (up previously from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th.

Guardian Pharmacy Services Trading Up 2.3%

GRDN opened at $21.78 on Wednesday. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $26.91. The firm’s fifty day moving average price is $23.19 and its two-hundred day moving average price is $22.01.

Guardian Pharmacy Services (NYSE:GRDN) last issued its earnings results on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.01). The firm had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million. On average, sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Insider Activity

In other news, Director William E. Bindley sold 3,508,905 shares of the business’s stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $20.16, for a total value of $70,739,524.80. Following the sale, the director now owns 2,591,271 shares in the company, valued at approximately $52,240,023.36. The trade was a 57.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thomas J. Salentine, Jr. sold 651,454 shares of the business’s stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total transaction of $13,133,312.64. Following the completion of the sale, the director now owns 1,939,817 shares in the company, valued at $39,106,710.72. This represents a 25.14% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 11,344,912 shares of company stock worth $228,713,426. Corporate insiders own 63.71% of the company’s stock.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.